News & Events
Explore our latest news, insights, and events.
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions
DeepHealth Expands Breast Suite with New FDA-Cleared AI Capabilities
DeepHealth has received FDA 510(k) clearances for Breast Arterial Calcification Assessment and prior exam integration into ProFound Pro. BAC Assessment is a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease.1 ProFound Pro with prior exam integration enables the comparison of breast tissue over time amongst prior and current exams, and will be brought to market as Mammo Dx.2
Annual Meeting of the German Society for Pediatric Radiology (GPR)
September 24-26, 2026
Tubingen, Germany
Congresso Brasileiro de Radiologia e Diagnóstico por Imagem | CBR 2026
September 17-19, 2026
Santa Rita Pier, Brazil
